| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,061 | 27,637 | 20,193 | 32,974 | | Cost of Revenue | 587 | 4,723 | 5,305 | (2,580) | | | Gross Profit | 35,474 | 22,914 | 14,888 | 35,554 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,423 | 3,464 | 2,675 | 3,861 | | Non Recurring | 15,870 | (10,759) | (5,111) |
-
| | Others | 9,097 | 7,506 | 7,326 | 10,596 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,084 | 22,702 | 9,998 | 21,098 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,072 | 210 | 266 | 464 | | Earnings Before Interest And Taxes | 19,157 | 22,912 | 10,265 | 21,562 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 19,157 | 22,912 | 10,265 | 21,562 | | Income Tax Expense | 7,043 | 8,476 | 3,799 | 7,981 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,113 | 14,436 | 6,465 | 13,581 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,113 | 14,436 | 6,465 | 13,581 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,113 | $14,436 | $6,465 | $13,581 |
|
0.51% Nasdaq 
Income Statement
